Standard Therapy
Showing 1 - 25 of >10,000
Gynecologic Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta (Manual Acupuncture)
Recruiting
- Gynecologic Cancer
- +3 more
- Manual Acupuncture
-
Jakarta, DKI Jakarta, IndonesiaSuryamin Hung
Oct 4, 2023
Oligozoospermia, Oligoasthenozoospermia, Oligoasthenoteratozoospermia Trial in Jakarta (Electroacupuncture and Standard Therapy)
Recruiting
- Oligozoospermia
- +2 more
- Electroacupuncture and Standard Therapy
-
Jakarta, Jakarta Timur, IndonesiaLisa Yunita
Oct 12, 2023
Gynecologic Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta Pusat, Jakarta (Electroacupuncture)
Recruiting
- Gynecologic Cancer
- +2 more
- Electroacupuncture
-
Jakarta Pusat, DKI Jakarta, Indonesia
- +2 more
Oct 4, 2023
Gynecologycal Cancer, Cancer Related Pain, Cancer Pain Trial in Jakarta Pusat, Jakarta (Press Needle Acupuncture)
Recruiting
- Gynecologycal Cancer
- +2 more
- Press Needle Acupuncture
-
Jakarta Pusat, DKI Jakarta, Indonesia
- +2 more
Nov 3, 2023
Nephrotic Syndrome Trial (Dapagliflozin and Standard therapy (ACEI or ARB)., Standard Therapy (ACEI or ARB).)
Not yet recruiting
- Nephrotic Syndrome
- Dapagliflozin and Standard therapy (ACEI or ARB).
- Standard Therapy (ACEI or ARB).
- (no location specified)
Jul 26, 2023
Gastrointestinal Cancer Trial (Capecitabine, Sacituzumab govetican)
Not yet recruiting
- Gastrointestinal Cancer
- Capecitabine
- Sacituzumab govetican
- (no location specified)
Oct 2, 2023
Advanced Solid Tumors With Neuroendocrine Differentiation Trial (surufatinib?serplulimab)
Not yet recruiting
- Advanced Solid Tumors With Neuroendocrine Differentiation
- (no location specified)
Nov 27, 2023
Acute Heart Failure Trial (Dexamethasone, Prednisone)
Not yet recruiting
- Acute Heart Failure
- (no location specified)
Mar 30, 2023
Colo-rectal Cancer Trial (biological, drug, procedure)
Not yet recruiting
- Colo-rectal Cancer
- Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
- +8 more
- (no location specified)
Aug 28, 2023
Solid Tumors Trial in Guangzhou (MASCT-I injection)
Completed
- Solid Tumors
- MASCT-I injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 25, 2023
Immune-related Adverse Events Refractory to Standard Therapy and
Recruiting
- Immune-related Adverse Event
- Extracorporeal photopheresis
- Other immunosuppressive or immunomodulatory drugs
-
Munich, GermanyLMU Klinikum Hauttumorzentrum
Jan 17, 2023
Effectiveness of Standard Therapy of Acne Vulgaris
Completed
- Acne Vulgaris
-
Jakarta Pusat, Jakarta, Indonesiadr.Cipto Mangunkusumo National Central General Hospital
Aug 7, 2023
Helicobacter Pylori Infection Trial in Santiago (Optimized bismuth quadruple therapy, Control)
Recruiting
- Helicobacter Pylori Infection
- Optimized bismuth quadruple therapy
- Control
-
Santiago, Metropolitana, Chile
- +1 more
Dec 21, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Columbus (Best Practice, Supportive Care, Survey
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Best Practice
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Oct 17, 2023
HER2-overexpressed Advanced Solid Tumors After Progression of
Not yet recruiting
- HER2
- +3 more
- Disitamab Vedotin
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Dec 14, 2022
Dysfunctional Voiding Trial in Istanbul (Exercise, Standard therapy)
Completed
- Dysfunctional Voiding
- Exercise
- Standard therapy
-
Istanbul, TurkeyHaliç University
Sep 13, 2023
Acne Vulgaris Trial in Mansoura (DAP-FLU ME, Adapalene .1% gel)
Not yet recruiting
- Acne Vulgaris
- DAP-FLU ME
- Adapalene .1% gel
-
Mansoura, EgyptAmgad El-Sayed Salem
Jun 10, 2023
Kidney Cancer Trial in Birmingham (Acarbose Tablets)
Not yet recruiting
- Kidney Cancer
- Acarbose Tablets
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 2, 2022
Solid Tumor Trial in Duarte (RNR inhibitor COH29, laboratory biomarker analysis, pharmacological study)
Suspended
- Unspecified Adult Solid Tumor, Protocol Specific
- RNR inhibitor COH29
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)
Not yet recruiting
- Locally Advanced Unresectable Gastric Cancer
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Aug 11, 2023
Colorectal Cancer Trial in Shanghai (HAIC, Fruquintinib, Tislelizumab)
Recruiting
- Colorectal Cancer
- HAIC
- +5 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 15, 2022
Tuberculosis, Pulmonary, HIV Trial in Port-au-Prince, Cape Town (Bedaquiline, Clofazimine, Pyrazinamide)
Not yet recruiting
- Tuberculosis, Pulmonary
- HIV
- Bedaquiline
- +6 more
-
Port-au-Prince, Haiti
- +1 more
Nov 11, 2022
Gastrointestinal Hemorrhage Trial (Hemostatic therapy, Endoscopic therapy with hemoclip +/- injection of epinephrine solution)
Not yet recruiting
- Gastrointestinal Hemorrhage
- Hemostatic therapy
- Endoscopic therapy with hemoclip +/- injection of epinephrine solution
- (no location specified)
Apr 30, 2022